Seminars in Nephrology
Volume 26, Issue 3 , Pages 224-233 , May 2006

Hereditary Polyuric Disorders: New Concepts and Differential Diagnosis

  • Daniel G. Bichet

      Affiliations

    • D.G.B. holds a Canada Research Chair in Genetics of Renal Diseases.
    • Corresponding Author InformationAddress reprint requests to Dr. Daniel G. Bichet, Research Centre, Hôpital du Sacré-Coeur de Montréal, 5400 Boulevard Gouin West, Montréal, Québec, H4J 1C5 Canada.

References 

  1. Bichet DG , Razi M , Lonergan M , et al.   Hemodynamic and coagulation responses to 1-desamino[8-D-arginine]vasopressin (dDAVP) infusion in patients with congenital nephrogenic diabetes insipidus . N Engl J Med . 1988;318:881–887
  2. Bichet DG , Razi M , Arthus MF , et al.   Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism . Kidney Int . 1989;36:859–866
  3. Verkman AS . Novel roles of aquaporins revealed by phenotype analysis of knockout mice . Rev Physiol Biochem Pharmacol . 2005;155:31–55
  4. Fredriksson R , Lagerstrom MC , Lundin LG , et al.   The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints . Mol Pharmacol . 2003;63:1256–1272
  5. Perez DM . The evolutionarily triumphant G-protein-coupled receptor . Mol Pharmacol . 2003;63:1202–1205
  6. Nielsen S , Frokiaer J , Marples D , et al.   Aquaporins in the kidney (From molecules to medicine) . Physiol Rev . 2002;82:205–244
  7. Tajkhorshid E , Nollert P , Jensen MO , et al.   Control of the selectivity of the aquaporin water channel family by global orientational tuning . Science . 2002;296:525–530
  8. Wade JB , Stetson DL , Lewis SA . ADH action (Evidence for a membrane shuttle mechanism) . Ann N Y Acad Sci . 1981;372:106–117
  9. van Balkom BW , Savelkoul PJ , Markovich D , et al.   The role of putative phosphorylation sites in the targeting and shuttling of the aquaporin-2 water channel . J Biol Chem . 2002;277:41473–41479
  10. Taylor A , Mamelak M , Reaven E , et al.   Vasopressin (Possible role of microtubules and microfilaments in its action) . Science . 1973;181:347–350
  11. Sabolic I , Katsura T , Verbabatz JM , et al.   The AQP2 water channel (Effect of vasopressin treatment, microtubule disruption, and distribution in neonatal rats) . J Membr Biol . 1995;143:165–177
  12. Yang B , Bankir L , Gillespie A , et al.   Urea-selective concentrating defect in transgenic mice lacking urea transporter UT-B . J Biol Chem . 2002;277:10633–10637
  13. Yang B , Bankir L . Urea and urine concentrating ability (New insights from studies in mice) . Am J Physiol . 2005;288:F881–F896
  14. Bankir L , Fernandes S , Bardoux P , et al.   Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans . J Am Soc Nephrol . 2005;16:1920–1928
  15. Ward DT , Hammond TG , Harris HW . Modulation of vasopressin-elicited water transport by trafficking of aquaporin2-containing vesicles . Annu Rev Physiol . 1999;61:683–697
  16. Bichet DG , Fujiwara TM . Nephrogenic diabetes insipidus . In:  Scriver CR ,  Beaudet AL ,  Sly WS , et al. editor. The Metabolic and Molecular Bases of Inherited Disease (vol 3, ed 8) . New York: McGraw-Hill; 2001;p. 4181–4204
  17. Arthus M-F , Lonergan M , Crumley MJ , et al.   Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus . J Am Soc Nephrol . 2000;11:1044–1054
  18. Morello JP , Salahpour A , Laperrière A , et al.   Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants . J Clin Invest . 2000;105:887–895
  19. Bernier V , Lagace M , Lonergan M , et al.   Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059 . Mol Endocrinol . 2004;18:2074–2084
  20. Hermosilla R , Oueslati M , Donalies U , et al.   Disease-causing V(2) vasopressin receptors are retained in different compartments of the early secretory pathway . Traffic . 2004;5:993–1005
  21. Wuller S , Wiesner B , Loffler A , et al.   Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors . J Biol Chem . 2004;279:47254–47263
  22. Schoneberg T , Schulz A , Biebermann H , et al.   Mutant G-protein-coupled receptors as a cause of human diseases . Pharmacol Ther . 2004;104:173–206
  23. Romisch K . A cure for traffic jams (Small molecule chaperones in the endoplasmic reticulum) . Traffic . 2004;5:815–820
  24. Cohen FE , Kelly JW . Therapeutic approaches to protein-misfolding diseases . Nature . 2003;426:905–909
  25. Bernier V , Lagace M , Bichet DG , et al.   Pharmacological chaperones (Potential treatment for conformational diseases) . Trends Endocrinol Metab . 2004;15:222–228
  26. Ulloa-Aguirre A , Janovick JA , Brothers SP , et al.   Pharmacologic rescue of conformationally-defective proteins (Implications for the treatment of human disease) . Traffic . 2004;5:821–837
  27. Bernier V , Morello J-P , Zarruk A , et al.   Pharmacological chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus . J Am Soc Nephrol . 2006;17:232–243
  28. Agre P . Aquaporin water channels (Nobel Lecture) . Angew Chem Int Ed Engl . 2004;43:4278–4290
  29. Kuwahara M , Iwai K , Ooeda T , et al.   Three families with autosomal dominant nephrogenic diabetes insipidus caused by aquaporin-2 mutations in the C-terminus . Am J Hum Genet . 2001;69:738–748
  30. Marr N , Bichet DG , Lonergan M , et al.   Heteroligomerization of an Aquaporin-2 mutant with wild-type Aquaporin-2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidus . Hum Mol Genet . 2002;11:779–789
  31. Kamsteeg E-J , Bichet DG , Konings IBM , et al.   Reversed polarized delivery of an aquaporin-2 mutant causes dominant nephrogenic diabetes insipidus . J Cell Biol . 2003;163:1099–1109
  32. de Mattia F , Savelkoul PJ , Bichet DG , et al.   A novel mechanism in recessive nephrogenic diabetes insipidus (Wild-type aquaporin-2 rescues the apical membrane expression of intracellularly retained AQP2-P262L) . Hum Mol Genet . 2004;13:3045–3056
  33. Bichet DG . Nephrogenic diabetes insipidus (New developments) . Nephrol Self Assess Prog . 2004;3:187–191
  34. Bichet DG , Fujiwara TM . Reabsorption of sodium chloride—lessons from the chloride channels . N Engl J Med . 2004;350:1281–1283
  35. Jeck N , Schlingmann KP , Reinalter SC , et al.   Salt handling in the distal nephron (Lessons learned from inherited human disorders) . Am J Physiol . 2005;288:R782–R795
  36. Peters M , Jeck N , Reinalter S , et al.   Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies . Am J Med . 2002;112:183–190
  37. Marek S , Tekesin I , Hellmeyer L , et al.   [Differential diagnosis of a polyhydramnion in hyperprostaglandin e syndrome: a case report.] . Z Geburtshilfe Neonatol . 2004;208:232–235
  38. Peters M , Ermert S , Jeck N , et al.   Classification and rescue of ROMK mutations underlying hyperprostaglandin E syndrome/antenatal Bartter syndrome . Kidney Int . 2003;64:923–932
  39. Ulinski T , Grapin C , Forin V , et al.   Severe bladder dysfunction in a family with ADH receptor gene mutation responsible for X-linked nephrogenic diabetes insipidus . Nephrol Dial Transplant . 2004;19:2928–2929
  40. Shalev H , Romanovsky I , Knoers NV , et al.   Bladder function impairment in aquaporin-2 defective nephrogenic diabetes insipidus . Nephrol Dial Transplant . 2004;19:608–613
  41. Yang B, Zhou D, Verkman AS: Mouse model of inducible nephrogenic diabetes insipidus produced by floxed aquaporin-2 gene deletion. Am J Physiol Renal Physiol 2006 (in press)
  42. Reinalter SC , Jeck N , Brochhausen C , et al.   Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome . Kidney Int . 2002;62:253–260
  43. Lorenz JN , Baird NR , Judd LM , et al.   Impaired renal NaCl absorption in mice lacking the ROMK potassium channel, a model for type II Bartter’s syndrome . J Biol Chem . 2002;277:37871–37880
  44. Bichet DG , Arthus M-F , Lonergan M , et al.   X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis . J Clin Invest . 1993;92:1262–1268
  45. Fujiwara TM , Bichet DG . Molecular biology of hereditary diabetes insipidus . J Am Soc Nephrol . 2005;16:2836–2846
  46. Mouillac B , Chini B , Balestre MN , et al.   The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions . J Biol Chem . 1995;270:25771–25777
  47. Deen PMT , Verdijk MAJ , Knoers NVAM , et al.   Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine . Science . 1994;264:92–95
  48. Bode HH , Crawford JD . Nephrogenic diabetes insipidus in North America (The Hopewell hypothesis) . N Engl J Med . 1969;280:750–754
  49. Bichet DG , Hendy GN , Lonergan M , et al.   X-linked nephrogenic diabetes insipidus (From the ship Hopewell to restriction fragment length polymorphism studies) . Am J Hum Genet . 1992;51:1089–1102
  50. Schlingmann KP , Konrad M , Jeck N , et al.   Salt wasting and deafness resulting from mutations in two chloride channels . N Engl J Med . 2004;350:1314–1319
  51. Laberge AM , Michaud J , Richter A , et al.   Population history and its impact on medical genetics in Quebec . Clin Genet . 2005;68:287–301
  52. Perry TL , Robinson GC , Teasdale JM , et al.   Concurrence of cystathioninuria, nephrogenic diabetes insipidus and severe anemia . N Engl J Med . 1967;276:721–725

 Supported by the Canadian Institutes of Health Research (MOP-8126), and by the Kidney Foundation of Canada.

PII: S0270-9295(06)00015-5

doi: 10.1016/j.semnephrol.2006.02.004

Seminars in Nephrology
Volume 26, Issue 3 , Pages 224-233 , May 2006

Article Tools

* Image Usage & Resolution